Nasdaq: BBTX · Listed Oct 30, 2026
Bambusa Therapeutics IPO
$15.90
▼ -2.75%today · -0.62% since the $16.00 IPO price
15-minute delayed · as of 7:30:02 PM EST on Nov 18, 2026
Bambusa Therapeutics (BBTX) priced its IPO at $16.00 a share and has traded on Nasdaq since Oct 30, 2026.
Last session · Nov 18, 2026
- Market cap
- $809.98M
- from the ticker reference
- Volume
- 190.48K
- shares, regular session
- VWAP
- $16.24
- the last price is -2.07% from the volume-weighted average
- Day range
- 15.91–16.52
- low to high
The trading numbers are from the last session, Nov 18, 2026.
The debut race
BBTX against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
BBTX against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Bambusa Therapeutics '26 | $168.89M | -7.00% | -6.31% | -1.69% | Not yet | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Bambusa Therapeutics IPO offers 10.56M shares to raise $168.89M, before any underwriters' option.
- Expected price range
- $15 to $17
- IPO price
- $16.00
- Shares offered
- 10.56M
- Money raised
- $168.89M
- Listing date
- Oct 30, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- Bambusa Therapeutics$168.89M
Where BBTX ranks
Bambusa Therapeutics's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- BBTX$809.98M
What comes after the IPO
Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.
Oct 30, 2026
First trade
Prices, bars, and snapshots
Nov 4, 2026 · est.
Options list
Option chain and open interest
Nov 19, 2026 · est.
First short interest
Short interest and daily short volume
Nov 24, 2026 · est.
Quiet period ends
Analyst ratings and price targets
Feb 14, 2027
First 13F deadline
Which funds hold the stock
Date not set
First earnings
Income statement and ratios
Apr 27, 2027 · est.
Lock-up expires
Insider sales on Form 4
Filings and the company
What Bambusa Therapeutics has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Bambusa Therapeutics discloses to the SEC on Form 8-K.
- Charter amendmentNov 3, 2026
On November 2, 2026, Bambusa Therapeutics, Inc. (the "Company") filed an amended and restated certificate of incorporation (the "Restated Certificate") with the Secretary of State of the State of Delaware in connection with the completion of the Company's initial public offering (the "IPO").
About Bambusa Therapeutics
Bambusa Therapeutics Inc is a clinical-stage biotechnology company developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases.
- Ticker
- BBTX
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Listed
- Oct 30, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the Bambusa Therapeutics IPO price?
$16.00 a share.
When did Bambusa Therapeutics go public?
Bambusa Therapeutics listed on Nasdaq on Oct 30, 2026 under the ticker BBTX.
How much did the Bambusa Therapeutics IPO raise?
$168.89M, before any underwriters' option.
How did Bambusa Therapeutics open on its first day?
BBTX first traded at $14.88, -7.00% from the IPO price of $16.00.
How did BBTX close on its first day?
Its last regular-session trade was $14.99, -6.31% from the IPO price of $16.00.
What was the BBTX first-day trading range?
$13.60 to $15.66 in the regular session.
How many BBTX shares traded on the first day?
2.03M shares in the regular session.
How many shares did Bambusa Therapeutics sell in its IPO?
10.56M shares.
What exchange is BBTX listed on?
Bambusa Therapeutics lists on Nasdaq under the ticker BBTX.
Are the prices on this page real time?
No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.
Build with Massive
Get the BBTX data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/BBTX/range/5/minute |
| Market cap | /v3/reference/tickers/BBTX |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.